Duvelisib For R/R Ptcl: Updates From The Primo Trial

Duvelisib for R/R PTCL: updates from the PRIMO trial

VJHemOnc – Video Journal of Hematology & HemOnc

Duvelisib plus romidepsin in r/r PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

Jasmine Zain, MD, shares outcomes from the PRIMO study investigating duvelisib in PTCL

PRIMO: Optimising the dose of duvelisib in patients with R/R peripheral T-cell lymphoma

The future of valemetostat in PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

PTCL Treatment in the Community Setting

Optimizing frontline treatment for PTCL: introducing novel agents into CHOP-based regimens

VJHemOnc – Video Journal of Hematology & HemOnc

Novel Agents and Chemotherapy Regimens in PTCL

Novel therapeutic regimens being explored in PTCL

VJHemOnc – Video Journal of Hematology & HemOnc

What excites you about the future direction of T cell lymphoma treatment?

British Society for Haematology

Does the addition of romidepsin to duvelisib enhance tumor responses in peripheral T-cell lymphoma?

Management of relapsed T-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Ptcl Account Registration Made Easy Check Bill And Data Usage Fast

Novel treatment strategies in T-cell lymphomas

VJHemOnc – Video Journal of Hematology & HemOnc

Update on Peripheral T-Cell Lymphoma Webinar | LRF Webinars

Lymphoma Research Foundation

New agents and therapeutic options for T-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Progress in Developing Novel Treatment Options for PTCL

PeerView Oncology

PTCL | Slow Internet Troubleshoot

Jasmine Zain, MD, discusses the most impressive studies in PTCL presented at ASH 2019

Immunoepigenetic platforms for PTCL treatment

VJHemOnc – Video Journal of Hematology & HemOnc